Tiansheng Pharmaceutical Group Co Ltd (002872) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.011x

Based on the latest financial reports, Tiansheng Pharmaceutical Group Co Ltd (002872) has a cash flow conversion efficiency ratio of -0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-22.57 Million ≈ $-3.30 Million USD) by net assets (CN¥1.97 Billion ≈ $288.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tiansheng Pharmaceutical Group Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Tiansheng Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Tiansheng Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tiansheng Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tiansheng Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Rane (Madras) Limited NSE:RML	0.032x
Arkade Developers Ltd NSE:ARKADE	-0.049x
Shenzhen Wongtee International Enterprise Co Ltd SHE:000056	-0.028x
Vine Hill Capital Investment Corp. II Class A Ordinary Shares NASDAQ:VHCP	-0.002x
SillaJen Inc KQ:215600	-0.040x
Shandong Kehui Power Automation Co Ltd SHG:688681	0.036x
Squirrel Media SA MC:SQRL	0.076x
Samsung Sdi Co Pref KO:006405	0.023x

Annual Cash Flow Conversion Efficiency for Tiansheng Pharmaceutical Group Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Tiansheng Pharmaceutical Group Co Ltd (002872) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.01 Billion ≈ $294.76 Million	CN¥50.15 Million ≈ $7.34 Million	0.025x	+312.41%
2023-12-31	CN¥2.10 Billion ≈ $306.66 Million	CN¥-24.56 Million ≈ $-3.59 Million	-0.012x	-128.75%
2022-12-31	CN¥2.19 Billion ≈ $320.11 Million	CN¥89.18 Million ≈ $13.05 Million	0.041x	+389.79%
2021-12-31	CN¥2.28 Billion ≈ $333.52 Million	CN¥18.97 Million ≈ $2.78 Million	0.008x	-89.52%
2020-12-31	CN¥2.39 Billion ≈ $349.69 Million	CN¥189.75 Million ≈ $27.77 Million	0.079x	+62.67%
2019-12-31	CN¥2.95 Billion ≈ $432.30 Million	CN¥144.21 Million ≈ $21.10 Million	0.049x	+0.86%
2018-12-31	CN¥3.18 Billion ≈ $465.60 Million	CN¥153.99 Million ≈ $22.53 Million	0.048x	+376.86%
2017-12-31	CN¥3.19 Billion ≈ $466.69 Million	CN¥-55.75 Million ≈ $-8.16 Million	-0.017x	-106.41%
2016-12-31	CN¥1.86 Billion ≈ $272.02 Million	CN¥506.68 Million ≈ $74.14 Million	0.273x	+107.92%
2015-12-31	CN¥1.63 Billion ≈ $238.37 Million	CN¥213.54 Million ≈ $31.25 Million	0.131x	-2.29%
2014-12-31	CN¥1.43 Billion ≈ $209.40 Million	CN¥191.99 Million ≈ $28.09 Million	0.134x	+153.41%
2013-12-31	CN¥1.08 Billion ≈ $157.71 Million	CN¥57.06 Million ≈ $8.35 Million	0.053x	-65.27%
2012-12-31	CN¥951.66 Million ≈ $139.26 Million	CN¥145.06 Million ≈ $21.23 Million	0.152x	--

About Tiansheng Pharmaceutical Group Co Ltd

SHE:002872 China Biotechnology

Market Cap

$229.41 Million

CN¥1.57 Billion CNY

Market Cap Rank

#16097 Global

#4612 in China

Share Price

CN¥4.93

Change (1 day)

-1.99%

52-Week Range

CN¥4.52 - CN¥5.70

All Time High

CN¥32.59